https://www.selleckchem.com/pr....oducts/a-438079-hcl.
Compared with A, T + A showed a higher 1-year vein graft patency rate in both on-pump (adjusted OR for non-patency =0.62, 95% CI 0.16-2.45) and off-pump (adjusted OR for non-patency =0.35, 95% CI 0.20-0.62) subgroups, P interaction =0.647; whereas T did not in either on-pump (adjusted OR for non-patency = 0.92, 95% CI 0.31-2.76) or off-pump (adjusted OR for non-patency =0.58, 95% CI 0.34-1.0 subgroups, P interaction =0.430. In the DACAB trial, for patients underwent either on-pump or off-pump CABG, ticagrelor plus aspirin showed
Like
Comment
Share
